论文信息 - Repurposing rosiglitazone, a PPAR‐&ggr; agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH - 字舞流文

Repurposing rosiglitazone, a PPAR‐&ggr; agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH

E. Nozik-Grayck | K. Stenmark | F. Ahsan | S. Hammouda | I. McMurtry | T. Al-Hilal | J. Rashid | A. Alobaida